Literature DB >> 12828917

Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury.

P K Lala1, C Chakraborty.   

Abstract

Impaired trophoblast invasiveness and spiral arterial remodelling, which results in poor placental perfusion during early pregnancy, is believed to cause fetal injury and growth retardation, and also endothelial cell activation/dysfunction in a susceptible mother, leading to clinical manifestations of pre-eclampsia. This article briefly reviews the regulatory roles of certain locally active factors in trophoblast migration and invasiveness. This background is then used to discuss and debate whether derangements or dysfunction of some of these factors can manifest as early serum markers predictive of the disease, as opposed to the intermediate and late stage markers which may reflect manifestations and consequences of the disease. Of particular significance are the observed derangements in uPA/uPAR/PAI system, IGFBP-1, HGF, HB-EGF and TGFbeta, factors which are known to regulate trophoblast migration and invasiveness in situ. An emphasis is placed on the need for longitudinal studies in order to identify predictive serum markers which may help strategies for prevention or amelioration of fetal injury and pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12828917     DOI: 10.1016/s0143-4004(03)00063-8

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  57 in total

Review 1.  The role of the invasive, placental trophoblast in human pregnancy.

Authors:  Jürgen Pollheimer; Martin Knöfler
Journal:  Wien Med Wochenschr       Date:  2012-05

Review 2.  Intrauterine trophoblast migration: A comparative view of humans and rodents.

Authors:  Juneo F Silva; Rogéria Serakides
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

3.  Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice.

Authors:  Manyu Li; Della Yee; Terry R Magnuson; Oliver Smithies; Kathleen M Caron
Journal:  J Clin Invest       Date:  2006-09-14       Impact factor: 14.808

Review 4.  Adrenomedullin and pregnancy: perspectives from animal models to humans.

Authors:  Patricia M Lenhart; Kathleen M Caron
Journal:  Trends Endocrinol Metab       Date:  2012-03-16       Impact factor: 12.015

5.  Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.

Authors:  Juanjuan Chen; Zongli Ren; Minglin Zhu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2017-05-12       Impact factor: 5.858

6.  Expression of ADAMTS13 in Normal and Abnormal Placentae and Its Potential Role in Angiogenesis and Placenta Development.

Authors:  Juan Xiao; Yun Feng; Xueyin Li; Wei Li; Lei Fan; Jing Liu; Xue Zeng; Kaiyue Chen; Xi Chen; Xiaoshui Zhou; X Long Zheng; Suhua Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-27       Impact factor: 8.311

7.  Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancy.

Authors:  Thomas W Bonagura; Gerald J Pepe; Allen C Enders; Eugene D Albrecht
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

8.  Placental oxidative stress alters expression of murine osteogenic genes and impairs fetal skeletal formation.

Authors:  M R Prater; C L Laudermilch; C Liang; S D Holladay
Journal:  Placenta       Date:  2008-09       Impact factor: 3.481

Review 9.  Mechanisms of trophoblast migration, endometrial angiogenesis in preeclampsia: The role of decorin.

Authors:  Peeyush K Lala; Pinki Nandi
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

Review 10.  Regional development of uterine decidualization: molecular signaling by Hoxa-10.

Authors:  Sanjoy K Das
Journal:  Mol Reprod Dev       Date:  2010-05       Impact factor: 2.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.